The fastest-spreading Ebola epidemic on record is tearing through central Africa, and the numbers are staggering. By the end of October, the Democratic Republic of the Congo had logged more than ten thousand confirmed infections and over five thousand deaths. The virus — specifically the Bundibugyo strain — has already slipped across borders into Kenya, Nigeria and Uganda, carried by the very human instinct to move, to trade, to flee conflict. For a weary British public still carrying the scars of Covid-19, the question hangs heavy: could it happen here? The honest answer is yes. A case could arrive tomorrow. But a case is not a crisis, and the difference between the two is where the real story lies.
A virus on the move
The geography of this outbreak reads like a map of vulnerability. Eastern DRC, the epicentre, is a region where armed groups control swathes of territory, where clinics have been burned and health workers threatened. Surveillance — the painstaking work of finding cases, tracing contacts, isolating the exposed — is not merely difficult; in places, it is impossible. Meanwhile, the arteries of commerce and kinship pulse across porous borders. Truck drivers, traders, families visiting relatives: they move in their thousands every day.
It took just one journey to plant the virus in Nairobi. A traveller moved from the DRC through Uganda into Kenya’s capital before falling ill. Weeks earlier, a humanitarian doctor returned to France carrying the infection home in her bloodstream. These are not hypotheticals. They are the mechanics of a globalised world. The UK Health Security Agency (UKHSA) monitors these pathways constantly. Since the virus was first identified in 1976, Britain has recorded precisely four imported cases. Not one resulted in a single onward transmission. Not one ended in death.
Not the pandemic we knew
When a haemorrhagic fever makes headlines, the mind instinctively reaches for the nearest template: Covid-19. But the comparison is a trap. SARS-CoV-2 spreads on the breath of asymptomatic strangers in a supermarket queue. Ebola demands intimacy. It passes through direct contact with the bodily fluids of someone already visibly, profoundly unwell — or through the contaminated bedding of a dying relative, the unwashed hands of a caregiver, the ritual washing of a loved one’s body.
This distinction changes everything. It means the virus cannot sustain silent chains of transmission in an office block or a classroom. It means the NHS, for all its pressures, possesses the infection control architecture to stop an imported case in its tracks: negative-pressure isolation rooms, rigorous PPE protocols, specialist high-consequence infectious disease units in London, Newcastle, Liverpool and Sheffield. The system has been tested. It has held.
The human cost behind the numbers
It is easy, from the safety of a London newsroom, to speak in statistics. Ten thousand cases. Five thousand deaths. But each figure represents a name, a family, a future severed. In North Kivu and Ituri provinces, parents have buried children. Children have watched parents vanish into treatment centres, never to return. The Bundibugyo strain kills roughly half of those it infects — a lower mortality than the notorious Zaire variant, but a coin toss no one should have to face.
And the survivors carry burdens that outlast the virus. Joint pain that lingers for years. Vision loss. Neurological sequelae. The stigma that follows them home, neighbours crossing the street, employers turning them away. The humanitarian response is stretched thin. Médecins Sans Frontières, the WHO, local Congolese teams — they operate under fire, sometimes literally, to deliver vaccines and supportive care. The rVSV-ZEBOV vaccine, a triumph of science, is being deployed in ring vaccination campaigns. But you cannot vaccinate a population you cannot reach.
Why it Matters
The risk of a UK epidemic remains vanishingly small, but the risk of complacency is real. Every imported case is a stress test of our preparedness — and a reminder that health security is not a domestic project. The next pandemic will not respect borders, and the strength of Britain’s defences depends on the strength of surveillance in Kinshasa, Goma, Nairobi. Investing in global health equity is not charity; it is the only rational insurance policy. When the next plane lands at Heathrow carrying a feverish passenger, the difference between a headline and a catastrophe will be the work done years earlier, thousands of miles away, in clinics we rarely think about.
